Management of Tooth Extraction in Patients Taking Antiresorptive Drugs: An Evidence Mapping Review and Meta-Analysis

Chang Liu, Yutao Xiong, Tao Zhu, Wei Liu, Wei Tang, Wei ZengJournal of Clinical Medicine 2022 · DOI

TL;DR

This evidence mapping review and meta-analysis synthesizes the current research on managing tooth extractions in patients taking antiresorptive drugs, a group at high risk for medication-related osteonecrosis of the jaw (MRONJ). The findings suggest that a drug holiday may not be beneficial and could even be harmful, while primary closure and antibacterial prophylaxis are recommended, despite the overall low quality of existing evidence.

What Problem Does This Paper Address?

Patients undergoing treatment with antiresorptive drugs (like bisphosphonates and denosumab) for conditions such as osteoporosis or cancer are at an increased risk of developing medication-related osteonecrosis of the jaw (MRONJ), particularly after tooth extractions. This severe complication can lead to significant morbidity. While tooth extractions are sometimes unavoidable, there's a critical need to understand the best management strategies to minimize MRONJ risk. This paper addresses the gap in clear, evidence-based guidelines by mapping and analyzing the existing research on interventions during tooth extraction in these vulnerable patients.

Methods

The researchers conducted a comprehensive evidence mapping review and meta-analysis. They systematically searched nine databases and two clinical trial registries for studies published up to November 2022. The review included primary studies (RCTs, non-randomized controlled trials, historical controlled trials, cohort studies) and secondary studies (systematic reviews, scoping reviews, umbrella reviews). The risk of bias for included studies was assessed using established tools like ROBIS for reviews, and RoB 2 and ROBINS-I for primary studies. Meta-analyses were performed using a random-effect model where appropriate, and results were synthesized using risk differences (RD) with 95% confidence intervals (CI).

Datasets

Not applicable. This paper is a systematic review and meta-analysis of existing literature, not an empirical study that collects new data or uses specific datasets for training or evaluation.

Key Insights and Ideas

  • Drug Holiday Controversy: The most striking finding is the questioning of the traditional "drug holiday" approach. The evidence suggests it might be unnecessary and potentially harmful, possibly increasing negative outcomes like fractures or tumor progression, which outweigh the MRONJ risk.
  • Low Quality of Evidence: A recurring theme is the consistently low to very low quality of evidence across all interventions examined. This highlights a significant need for more robust research.
  • Limited Efficacy of APCs: Autologous platelet concentrates (APCs), such as PRF, PRGF, and PRP, showed uncertain efficacy in preventing MRONJ after extraction, despite being explored in several studies.
  • Surgical Techniques Unclear: The evidence comparing different surgical techniques for extraction in this patient group was insufficient to draw firm conclusions.
  • Antibacterial Prophylaxis Promising (but limited evidence): While only one study directly compared antibacterial prophylaxis to a control, the results were strongly in favor of prophylaxis, suggesting it could be beneficial.

Key Results

  • Drug Holiday vs. Continuation: No significant risk difference was found between drug holiday and drug continuation for MRONJ incidence, except for one subgroup where drug continuation showed a reduced incidence proportion with over a 3-month follow-up. Secondary outcomes in one study showed no significant difference in complications or tumor progression between groups.
  • APC vs. Control: The efficacy of APCs in preventing MRONJ was generally not statistically different from control groups. However, one study showed a significant reduction in MRONJ incidence with PRGF compared to control over a 24-month follow-up.
  • Antibacterial Prophylaxis vs. Control: A single retrospective cohort study found a significant risk difference of -0.57 (95% CI -0.85 to -0.29) favoring antibacterial prophylaxis, with no MRONJ cases in the prophylaxis group compared to eight in the control group.

Limitations and Future Work

The authors acknowledge several limitations:

  • Internal Validity: The internal validity of the included primary studies was significantly degraded due to a high risk of bias, particularly detection bias and confounding in non-randomized studies.
  • External Validity: Remarkable clinical heterogeneity existed across studies regarding drug types, doses, indications, and patient populations, limiting generalizability.
  • Sample Size: Many primary studies lacked sample size calculations, leading to imprecise evidence.
  • Review Limitations: The inclusion of non-randomized studies in the review may have degraded the overall quality of evidence. The potential for publication bias could not be definitively assessed due to the limited number of studies in some comparisons.

The authors strongly recommend future research focusing on prospective, controlled clinical studies with good quality and large sample sizes. Double-blind RCTs are considered the gold standard, with careful consideration for blinding of participants, personnel, and outcome assessors. For non-randomized studies, appropriate statistical analyses like regression and inverse probability weighting are suggested to mitigate confounding bias.

Summary updated

Abstract

There is limited evidence to demonstrate that a drug holiday is unnecessary (and may in fact be potentially harmful) in dental practice. Primary closure and antibacterial prophylaxis are recommended despite limited evidences. All evidence have been graded as either of a low or very low quality, and thus further high-quality randomized controlled trials are needed to answer this clinical question.
BibTeX
@article{liu2022management,
  author = {Chang Liu and Yutao Xiong and Tao Zhu and Wei Liu and Wei Tang and Wei Zeng},
  title = {{Management of Tooth Extraction in Patients Taking Antiresorptive Drugs: An Evidence Mapping Review and Meta-Analysis}},
  journal = {Journal of Clinical Medicine},
  year = {2022},
  doi = {10.3390/jcm12010239},
}
Figure